What is CG Oncology's PP&E (net)?

CG Oncology (CGON) reported PP&E (net) of $15.07M in Q1 2026.

How has CG Oncology's PP&E (net) changed year-over-year?

CG Oncology's PP&E (net) increased by 5609.8% year-over-year, from $264K to $15.07M.

What is the long-term trend for CG Oncology's PP&E (net)?

Over 2 years (2023 to 2025), CG Oncology's PP&E (net) has grown at a 1403.4% compound annual growth rate (CAGR), from $69K to $15.6M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

CG Oncology CGON PP&E (Net)

PP&E (Net) at other companies

PfizerPFE

$19.4B+5.8%

Johnson & JohnsonJNJ

$23.27B+11.5%

Gilead SciencesGILD

$5.64B+4.0%

ImmunityBio, Inc.IBRX

$112.79M-16.6%

Cogent Biosciences, Inc.COGT

$5.3M-17.9%

Tango TherapeuticsTNGX

$6.38M-15.4%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's PP&E (net)?: CG Oncology (CGON) reported PP&E (net) of $15.07M in Q1 2026.
How has CG Oncology's PP&E (net) changed year-over-year?: CG Oncology's PP&E (net) increased by 5609.8% year-over-year, from $264K to $15.07M.
What is the long-term trend for CG Oncology's PP&E (net)?: Over 2 years (2023 to 2025), CG Oncology's PP&E (net) has grown at a 1403.4% compound annual growth rate (CAGR), from $69K to $15.6M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.